{
  "docId": "019de075-d8f1-727b-b893-5e9d6af9a579",
  "docSlug": "880c8a38f766d3eb6660c74e922f5744",
  "documentTitle": "MindMed | Investor Presentation Deck | 32 slides",
  "authorId": "mindmed",
  "authorName": "MindMed",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 14,
  "pageCount": 32,
  "prevPage": 13,
  "nextPage": 15,
  "slideType": "appendix_methodology",
  "function": "plan_implementation",
  "density": "dense",
  "nDataPoints": 1,
  "notes": "The slide uses a timeline-based diagram to illustrate the clinical trial protocol.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-d8f1-727b-b893-5e9d6af9a579/14",
  "deckHref": "/decks/019de075-d8f1-727b-b893-5e9d6af9a579",
  "deckJsonHref": "/decks/019de075-d8f1-727b-b893-5e9d6af9a579.json",
  "deckAnchorHref": "/decks/019de075-d8f1-727b-b893-5e9d6af9a579#slide-14",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.3,
        "x": 0.65,
        "y": 0.2
      },
      "kind": "callout",
      "text": "Study MMED008 | MM-120 for GAD",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3f73fb66-da51-4b25-9f1f-437ad4f6df12",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.4,
        "x": 0.15,
        "y": 0.25
      },
      "kind": "diagram",
      "text": "Study timeline showing weeks -5 to 12, randomization, and follow-up periods.",
      "attrs": null,
      "subkind": "timeline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "643ae473-e895-47df-8cfc-2564a89fb85e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.25,
        "x": 0.67,
        "y": 0.45
      },
      "kind": "list",
      "text": "Key Entry Criteria: Men and Women, Ages 18-74, Diagnosis of GAD, HAM-A >= 20",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e3376b4d-64ff-4dae-9ee0-3f28b1bd7bf6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.25,
        "x": 0.67,
        "y": 0.65
      },
      "kind": "list",
      "text": "Additional Endpoints: MADRS, CGI-S/I, PGI-S/C, SDS, EQ-5D-5L, PSQI, ASEX",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ffd41110-a3d0-42c5-ae89-152de3409730",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.05,
        "y": 0.85
      },
      "kind": "source-note",
      "text": "Source: MindMed internal study documents. Abbreviations defined.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "61ad0bc9-9edd-4488-9d75-6bdf804d2f6d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.6,
        "x": 0.05,
        "y": 0.1
      },
      "kind": "subtitle",
      "text": "Study design seeks to evaluate dose-responsive effects and identify optimal dose for pivotal clinical trials",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7737934e-9912-41b7-96e6-dbde7377aab1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Phase 2b Generalized Anxiety Disorder (GAD)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "db550bf1-0842-4be1-92f1-6dd6968d3d74",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "SCQA Framework",
      "slug": "scqa-framework",
      "agent": "Architect",
      "layer": "slide",
      "matchId": "84bef519-99c0-4ba2-8a37-f1b0ff63c9e2",
      "evidence": "The slide is structured with a clear Situation (study design), Complication (dose-responsive effects and optimal dose), Question (evaluate dose-responsive effects), and Answer (study results).",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "gantt-chart",
      "slug": null,
      "matchId": "c5fde821-a2fa-4767-a3f2-35dad9b21bb9",
      "evidence": "Timeline visualization of clinical trial phases",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 14,
      "from": 13,
      "beatId": "ce8cae4b-4547-4a71-ae4e-e1065f111172",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Traction",
      "beatSlug": null,
      "evidence": "Traction is shown on pages 13-14 with results from UHB's LSD-Assist study.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}